About Potassium channel subfamily K member 7
Potassium channel subfamily K member 7 (KCNK7) is a protein
from Homo sapiens identified by UniProt accession
Q9Y2U2, 307 residues long.
MolForge cross-references it against 0 known binders and
48 disease associations.
Target properties
| Protein name | Potassium channel subfamily K member 7 |
| UniProt accession | Q9Y2U2 |
| Gene | KCNK7 |
| Organism | Homo sapiens |
| Length | 307 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (48)
Diseases linked to this target (Open Targets).
- breast adenocarcinoma · score 0.22
- aspartate aminotransferase measurement · score 0.17
- cutaneous melanoma · score 0.16
- calcium measurement · score 0.14
- glucose measurement · score 0.11
- total cholesterol measurement · score 0.10
- serum albumin measurement · score 0.09
- sex hormone-binding globulin measurement · score 0.09
- mean corpuscular hemoglobin · score 0.08
- Red cell distribution width · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9Y2U2-F1 | alphafold | PREDICTED | 82.43 | — |
Amino-acid sequence (307 residues)
MGGLRPWSRY GLLVVAHLLA LGLGAVVFQA LEGPPACRLQ AELRAELAAF QAEHRACLPP GALEELLGTA LATQAHGVST LGNSSEGRTW DLPSALLFAA SILTTTGYGH MAPLSPGGKA FCMVYAALGL PASLALVATL RHCLLPVLSR PRAWVAVHWQ LSPARAALLQ AVALGLLVAS SFVLLPALVL WGLQGDCSLL GAVYFCFSSL STIGLEDLLP GRGRSLHPVI YHLGQLALLG YLLLGLLAML LAVETFSELP QVRAMGKFFR PSGPVTAEDQ GGILGQDELA LSTLPPAAPA SGQAPAC
Explore Potassium channel subfamily K member 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets